[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018-2023 Global Plasma Fraction Market Report (Status and Outlook)

August 2018 | 115 pages | ID: 21E4A9C5A5FEN
LP Information

US$ 4,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Plasma Fraction market for 2018-2023.

Blood plasma fractionation refers to the general processes of separating the various components of blood plasma, which in turn is a component of blood obtained through blood fractionation.
Increasing awareness about the disease and increasing disposable income are expected to boost the growth of the plasma fraction market.
Over the next five years, LPI(LP Information) projects that Plasma Fraction will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Plasma Fraction market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:
  • Protease Inhibitors
  • Protease
  • Coagulation Factors
  • Anti-Coagulant Proteins
Segmentation by application:
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
We can also provide the customized separate regional or country-level reports, for the following regions:
  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Spain
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
  • Baxter
  • Octapharma
  • Biotest
  • CSL
  • Grifols
  • Kedrion
  • LFB
  • Chinese Biological Products
  • Shanghai RAAS Blood Products
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  • To study and analyze the global Plasma Fraction market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
  • To understand the structure of Plasma Fraction market by identifying its various subsegments.
  • Focuses on the key global Plasma Fraction players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Plasma Fraction with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the size of Plasma Fraction submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Plasma Fraction Market Size 2013-2023
  2.1.2 Plasma Fraction Market Size CAGR by Region
2.2 Plasma Fraction Segment by Type
  2.2.1 Protease Inhibitors
  2.2.2 Protease
  2.2.3 Fibrinolytic Proteins
  2.2.4 Coagulation Factors
  2.2.5 Anti-Coagulant Proteins
2.3 Plasma Fraction Market Size by Type
  2.3.1 Global Plasma Fraction Market Size Market Share by Type (2013-2018)
  2.3.2 Global Plasma Fraction Market Size Growth Rate by Type (2013-2018)
2.4 Plasma Fraction Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Ambulatory Surgical Centers
2.5 Plasma Fraction Market Size by Application
  2.5.1 Global Plasma Fraction Market Size Market Share by Application (2013-2018)
  2.5.2 Global Plasma Fraction Market Size Growth Rate by Application (2013-2018)

3 GLOBAL PLASMA FRACTION BY PLAYERS

3.1 Global Plasma Fraction Market Size Market Share by Players
  3.1.1 Global Plasma Fraction Market Size by Players (2016-2018)
  3.1.2 Global Plasma Fraction Market Size Market Share by Players (2016-2018)
3.2 Global Plasma Fraction Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PLASMA FRACTION BY REGIONS

4.1 Plasma Fraction Market Size by Regions
4.2 Americas Plasma Fraction Market Size Growth
4.3 APAC Plasma Fraction Market Size Growth
4.4 Europe Plasma Fraction Market Size Growth
4.5 Middle East & Africa Plasma Fraction Market Size Growth

5 AMERICAS

5.1 Americas Plasma Fraction Market Size by Countries
5.2 Americas Plasma Fraction Market Size by Type
5.3 Americas Plasma Fraction Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Plasma Fraction Market Size by Countries
6.2 APAC Plasma Fraction Market Size by Type
6.3 APAC Plasma Fraction Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Plasma Fraction by Countries
7.2 Europe Plasma Fraction Market Size by Type
7.3 Europe Plasma Fraction Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Plasma Fraction by Countries
8.2 Middle East & Africa Plasma Fraction Market Size by Type
8.3 Middle East & Africa Plasma Fraction Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL PLASMA FRACTION MARKET FORECAST

10.1 Global Plasma Fraction Market Size Forecast (2018-2023)
10.2 Global Plasma Fraction Forecast by Regions
  10.2.1 Global Plasma Fraction Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Plasma Fraction Forecast by Type
10.8 Global Plasma Fraction Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Baxter
  11.1.1 Company Details
  11.1.2 Plasma Fraction Product Offered
  11.1.3 Baxter Plasma Fraction Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Baxter News
11.2 Octapharma
  11.2.1 Company Details
  11.2.2 Plasma Fraction Product Offered
  11.2.3 Octapharma Plasma Fraction Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Octapharma News
11.3 Biotest
  11.3.1 Company Details
  11.3.2 Plasma Fraction Product Offered
  11.3.3 Biotest Plasma Fraction Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Biotest News
11.4 CSL
  11.4.1 Company Details
  11.4.2 Plasma Fraction Product Offered
  11.4.3 CSL Plasma Fraction Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 CSL News
11.5 Grifols
  11.5.1 Company Details
  11.5.2 Plasma Fraction Product Offered
  11.5.3 Grifols Plasma Fraction Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Grifols News
11.6 Kedrion
  11.6.1 Company Details
  11.6.2 Plasma Fraction Product Offered
  11.6.3 Kedrion Plasma Fraction Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Kedrion News
11.7 LFB
  11.7.1 Company Details
  11.7.2 Plasma Fraction Product Offered
  11.7.3 LFB Plasma Fraction Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 LFB News
11.8 Chinese Biological Products
  11.8.1 Company Details
  11.8.2 Plasma Fraction Product Offered
  11.8.3 Chinese Biological Products Plasma Fraction Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Chinese Biological Products News
11.9 Shanghai RAAS Blood Products
  11.9.1 Company Details
  11.9.2 Plasma Fraction Product Offered
  11.9.3 Shanghai RAAS Blood Products Plasma Fraction Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 Shanghai RAAS Blood Products News

12 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES AND FIGURES

Table Product Specifications of Plasma Fraction
Figure Plasma Fraction Report Years Considered
Figure Market Research Methodology
Figure Global Plasma Fraction Market Size Growth Rate 2013-2023 (


More Publications